Legend Biotech (LEGN) Cash from Investing Activities (QoQ) (2019 - 2025)
Legend Biotech (LEGN) Cash from Investing Activities (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,292.34% |
| Sep 30, 2025 | 87.92% |
| Jun 30, 2025 | -164.50% |
| Mar 31, 2025 | 391.97% |
| Dec 31, 2024 | -126.71% |
| Sep 30, 2024 | 147.31% |
| Jun 30, 2024 | -75.60% |
| Mar 31, 2024 | -197.21% |
| Dec 31, 2023 | 294.91% |
| Sep 30, 2023 | -71.82% |
| Jun 30, 2023 | -859.00% |
| Mar 31, 2023 | 120.46% |
| Dec 31, 2022 | -161.26% |
| Sep 30, 2022 | 4,847.43% |
| Jun 30, 2022 | 101.11% |
| Mar 31, 2022 | -19.24% |
| Dec 31, 2021 | -84.52% |
| Sep 30, 2021 | 37.35% |
| Jun 30, 2021 | -883.52% |
| Mar 31, 2021 | 29.04% |